Immunotherapies used to treat melanoma of the skin are commonly used, however, these are markedly less effective for metastatic uveal melanoma.” Hepzato is unlikely to be widely available in the ...

It has long been known that histologic features such as epithelioid melanoma cytomorphology, closed laminin loops, and mitotic count are associated with increased mortality, but these have not ...

Uveal melanoma is the most common primary malignancy of the eye and frequently leads to metastatic death. Until the mid-20th Century, the only treatment for uveal melanoma was enucleation.

D models of uveal melanoma are transforming cancer research, enabling personalized treatments and better drug testing for ...

Get Instant Summarized Text (Gist) Organoid models have been developed to study uveal melanoma, a common adult eye cancer, using patient-derived tissue to create accurate 3D models. These ...

Tebentafusp is recommended, within its marketing authorisation, for treating HLA‑A*02:01-positive unresectable or metastatic uveal melanoma in adults. Tebentafusp is only recommended if the company ...

Chief executive and founder of Ocular Melanoma UK Jo Gumbs described the announcement as "simply incredible." She added: "For too long, metastatic uveal melanoma has been a devastating cancer so ...

Detailed price information for Delcath Systems Inc (DCTH-Q) from The Globe and Mail including charting and trades.

Replimune Group Inc (NASDAQ:REPL), a biotechnology company specializing in oncolytic immunotherapy for cancer treatment, ...

Analyst Patrick Trucchio of H.C. Wainwright reiterated a Buy rating on Immunocore Holdings (IMCR – Research Report), retaining the price target ...